Remove Hormones Remove Life Science Remove Radiology
article thumbnail

Bayer delivers on medical innovation fueling transformation of pharma business

The Pharma Data

Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.

article thumbnail

Meeting public expectations of diagnostics is the next big test for the NHS

pharmaphorum

Estimates of medical diagnostics worth to the UK vary – MedTech Europe puts its value at around £1billion while the Office for Life Sciences reported in 2018 that it accounts for around 27% of the £24 billion turnover generated annually by the UK’s medtech sector.

article thumbnail

Women’s Health Clinical Trials: Clinical Innovations, Opportunities and Considerations

XTalks

Misconceptions and Biases: Despite the known physiologic, metabolic and hormonal differences between men and women, there remains a long-standing misconception that drugs exert the same effects in both men and women. There is a growing recognition of the need for inclusive research that accurately reflects the diverse experiences of women.